Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in patients with non-Hodgkin's lymphoma in the United Kingdom (UK)

Whyte, S., Cooper, K.L., Stevenson, M.D. et al. (1 more author) (2011) Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in patients with non-Hodgkin's lymphoma in the United Kingdom (UK). HEDS Discussion Paper (11-02).

Abstract

Metadata

Authors/Creators:
  • Whyte, S. (sophie.whyte@sheffield.ac.uk)
  • Cooper, K.L. (k.l.cooper@sheffield.ac.uk)
  • Stevenson, M.D. (m.d.stevenson@sheffield.ac.uk)
  • Akehurst, R. (r.l.akehurst@sheffield.ac.uk)
Keywords: cost-effectiveness; economic model; febrile neutropenia; granulocyte colony–stimulating factors; prophylaxis; non-Hodgkin’s lymphoma
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Health Economics and Decision Science > HEDS Discussion Paper Series
Depositing User: ScHARR / HEDS (Sheffield)
Date Deposited: 31 Oct 2012 09:34
Last Modified: 05 Jun 2014 12:52
Status: Published

Download

Filename: 11.02.pdf

Share / Export